Full Breakdown
2026 Medicare Advantage Star Ratings: A Mixed Bag for Major Insurers
10/12/2025, 2:22:29 AM
Overview of the 2026 Star Ratings
The Centers for Medicare & Medicaid Services (CMS) released the 2026 Medicare Advantage (MA) star ratings, revealing a generally stable landscape for major insurers after several years of declines. The average star rating increased slightly from 3.96 to 3.98, indicating resilience in the industry despite heightened regulatory standards. However, significant variations emerged among the largest players, including UnitedHealthcare, Aetna, Humana, Elevance Health, and Centene.
Performance of Major Insurers
UnitedHealthcare, the largest MA insurer, reported that over 77% of its 10.3 million members are enrolled in plans rated four stars or higher, a slight increase from the previous year. Aetna, now a subsidiary of CVS Health, follows closely with 81% of its 4.2 million members in top-rated plans, although this marks a decline from 89% in 2025. Elevance Health improved its standing, with 55% of its 2.2 million members in plans rated four stars or higher, up from 40% last year. In contrast, Humana experienced a significant drop, with only 20% of its 5.8 million members in highly rated plans, down from 25% in 2025.
Clover Health emerged as a notable loser, with its largest contract dropping below the four-star threshold, potentially jeopardizing tens of millions in earnings. Conversely, Alignment Healthcare achieved a remarkable feat, maintaining 100% of its members in plans rated four stars or higher for the second consecutive year.
Financial Implications of Star Ratings
The star ratings directly influence the financial landscape for insurers, as higher ratings correlate with substantial government bonus payments. Insurers with lower ratings may face reduced revenues, prompting potential cuts to supplemental benefits or increases in premiums. Analysts predict that the decline in ratings for companies like Humana could lead to strategic shifts as they seek to regain competitive advantages.
Criticism and Challenges
Clover Health criticized the CMS's rating methodology, asserting that it does not accurately reflect the health outcomes delivered to its members. This sentiment highlights ongoing tensions between insurers and regulatory bodies as they navigate the complexities of quality assessments. Additionally, the overall decline in ratings for some insurers raises concerns about their ability to maintain market share amid increasing competition.
Official Statements
Aetna President Steve Nelson expressed pride in the company's performance, emphasizing its commitment to delivering exceptional care experiences. UnitedHealthcare reiterated its dedication to quality, stating, "We continue to have more members in plans rated 4-star or higher than any other carrier in the industry." Meanwhile, Humana acknowledged its disappointing results but anticipates improvements in future ratings.
Conclusion: The Road Ahead
As the Medicare Advantage landscape evolves, insurers are under pressure to enhance care quality and member satisfaction. The 2026 star ratings serve as a critical benchmark for performance, influencing both consumer choices and financial outcomes for insurers. With the annual enrollment period approaching, beneficiaries will rely on these ratings to guide their health coverage decisions, while insurers must adapt to the shifting regulatory environment to secure their positions in the market.
